Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

ImmunoQ Therapeutics Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

ImmunoQ Therapeutics Inc.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: KW12VEXTQXP7

Founded: —Source: [GOV]
Headquarters: Bellaire, TexasSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

ImmunoQ Therapeutics Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $395,738 in 2022. These are non-dilutive federal research grants, not equity financing. The company is based in Bellaire, Texas.

Funding rounds

1 rounds

STTR Phase I award (HHS)GrantJun 2022Source: [GOV]
$395.7K
—post-money

Investors

No investors recorded yet for ImmunoQ Therapeutics Inc..

Add an investor

People

Leadership

SHUHSIA CHENPrincipal investigatorSince 2022Source: [GOV]

Acquisitions

ImmunoQ Therapeutics Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for ImmunoQ Therapeutics Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.